查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2002692

伽瑪刀市場：全球市場按產品類型、應用、最終用戶和分銷管道分類的預測 - 2026-2032年

Gamma Knife Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年伽瑪刀市值為 4.0105 億美元，預計到 2026 年將成長至 4.3111 億美元，複合年成長率為 7.13%，到 2032 年將達到 6.4968 億美元。

主要市場統計數據
基準年 2025 4.0105億美元
預計年份：2026年 4.3111億美元
預測年份 2032 6.4968億美元
複合年成長率 (%) 7.13%

簡要概述影響伽瑪刀放射線手術技術的商業性趨勢、其臨床整合以及採購和服務模式。

伽瑪刀立體定位放射放射線手術仍然是神經外科和放射外科治療模式中的基石技術，它將亞毫米級的靶向精度與非侵入性放射治療相結合，用於治療複雜的顱內病變。該系列設備包括傳統平台和現代平台，它們在束流照射架構、工作流程整合以及配套的成像和計劃軟體方面各不相同。臨床相關人員持續優先考慮那些能夠最大限度減少患者固定時間、最佳化處理能力並與涵蓋神經外科、放射腫瘤科和神經腫瘤科的多學科診療路徑相整合的系統。

臨床進步、工作流程效率的提高以及籌資策略的演變，正在如何改變醫療服務提供者在放射外科服務領域的採用趨勢和供應商競爭格局？

伽瑪刀領域正經歷一場變革，其驅動力包括技術創新、臨床路徑的演進以及商業性模式的轉變。立體定位治療計劃演算法的進步、與高解析度磁振造影技術的整合以及無框架工作流程的出現，拓展了伽瑪刀的適應症，改善了患者體驗，促使更多醫療機構將放射放射線手術作為某些腦部病變的標準治療方案進行評估。這些臨床進展，加上治療效率的提升（影響治療的地點和方式），使得伽瑪刀的推廣應用不再侷限於傳統的三級醫療機構。

我們將評估累積關稅措施和進口限制對放射線手術系統採購時間、供應商定價策略和供應鏈韌性的影響。

關稅政策的最新變化為伽瑪刀系統的資本投資計畫和供應鏈韌性帶來了新的變數。累積關稅及相關的進口限制將影響複雜醫療設備、組件和軟體整合硬體的升級總成本，並可能對供應商的定價策略和醫療機構的採購時間產生連鎖反應。採購團隊正日益將關稅情境規劃納入資本投資核准流程，以確保儲備資金，並避免因海關程序和供應商價格調整而導致計劃延誤。

透過詳細的細分框架，提供可操作的見解，展示通路、最終用戶、臨床應用和產品模型如何決定產品引入途徑和售後市場需求。

詳細的細分分析揭示了不同分銷管道、最終用戶、應用領域和產品類型在採用促進因素和商業化路徑上的差異。分銷通路趨勢包括電子商務舉措、包含專屬OEM銷售團隊的直銷模式，以及透過區域和全國分銷商網路運營的經銷商主導管道。每種模式都會影響前置作業時間、服務應對力和捆綁銷售機會。最終使用者細分涵蓋範圍廣泛，從注重工作流程效率的門診手術中心（包括放射科和外科中心），到涵蓋區域醫療機構和擁有綜合多專科項目的三級醫療中心的醫院，甚至包括優先考慮特定手術處理能力和臨床療效的專科診所，例如神經外科中心和腫瘤科診所。

區域法規結構、報銷趨勢以及醫療服務提供者基礎設施的差異如何影響全球主要地區的部署模式和商業性模式？

區域趨勢對伽瑪刀系統的臨床部署模式、法規要求和商業性發展有顯著影響。在美洲，大規模大學醫院和區域醫院系統都會影響採購決策，其報銷結構和網路層面的資本規劃決定了升級和新部署的速度。隨著按次付費的模式和病患處理能力的提升，門診治療模式正在不斷擴展，分散式放射外科手術得以開展；與此同時，都市區三級醫療機構也持續投資於綜合多重模式治療計畫。

為什麼產品差異化、生命週期服務卓越性和通路夥伴關係決定了放射線手術領域的競爭優勢和長期供應商合作關係。

在伽瑪刀及更廣泛的立體定位放射放射線手術市場中，競爭地位取決於產品差異化、全生命週期服務能力和銷售管道執行力的綜合考量。領先供應商專注於展示臨床精準性、工作流程整合性和長期可維護性，而鄰近的競爭對手則強調提供替代性束流照射技術和混合療法，以吸引尋求多功能平台的醫療機構。原始設備製造商 (OEM) 與醫院系統之間的策略夥伴關係日益重視現有設備的升級、培訓以及軟體驅動的臨床決策支持，以此作為維持長期合作關係的手段。

供應商和服務商需要採取切實可行的策略措施，協調產品創新、商業性柔軟性和服務能力，以加速產品部署並降低政策風險。

產業領導企業應採取多管齊下的策略，抓住放射外科領域的成長機遇，同時應對臨床、商業性和政策方面的挑戰。首先，應使產品藍圖與臨床醫生的需求保持一致，優先考慮無框架工作流程、先進的影像整合和自動化規劃，以縮短治療時間並擴大患者群體。持續投資於臨床證據的產生和同儕審查的治療結果數據，能夠增強採購說服力，並促進其融入標準化治療路徑。

採用透明的混合方法研究途徑，結合相關人員訪談和二手證據的整合，檢驗臨床和商業性發現。

本分析整合了混合研究途徑結合了與關鍵相關人員的直接互動和嚴謹的二手研究。主要互動包括與臨床負責人、採購專家、臨床工程師和供應商客戶經理進行結構化訪談和討論，以了解他們對設備選擇標準、工作流程優先順序和合約偏好的實際觀點。透過這些對話，我們對不同類型醫療機構在設備採用、服務期望和升級理由方面面臨的各種障礙有了定性理解。

以策略重點、供應鏈韌性和證據一致性為核心的最終整合，旨在支持放射外科的永續實施。

總之，伽瑪刀領域正處於一個轉折點，臨床創新、供應鏈趨勢和不斷演變的採購模式在此交匯融合。積極適應無框架工作流程、投資可互通的規劃和成像解決方案並部署靈活商業模式的醫療機構和供應商，將更有利於抓住新的市場需求並加強長期夥伴關係。價格上漲帶來的成本壓力凸顯了供應鏈多元化和本地服務基礎設施的重要性，以維持部署進度並確保總生命週期成本的可預測性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：伽瑪刀市場：依產品類型分類

  • 4C
    • 新推出
    • 升級
  • Icon
    • 新推出
    • 升級
  • C型
    • 新推出
    • 升級
  • Perfexion
    • 新推出
    • 升級

第9章：伽瑪刀市場：依應用領域分類

  • 腦腫瘤
    • 轉移性腦瘤
    • 原發性腦腫瘤
  • 功能性障礙
    • 運動障礙
    • 三叉神經痛
  • 血管畸形
    • 動靜脈畸形
    • 海綿狀畸形

第10章：伽瑪刀市場：依最終用戶分類

  • 門診手術中心
    • 放射治療中心
    • 外科中心
  • 醫院
    • 當地醫院
    • 三級醫療醫院
  • 專科診所
    • 神經外科中心
    • 腫瘤診所

第11章：伽瑪刀市場：依分銷管道分類

  • 直銷
    • 電子商務
    • OEM銷售團隊
  • 銷售代理
    • 區域代理
    • 全國銷售代理

第12章：伽瑪刀市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：伽瑪刀市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：伽瑪刀市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國伽瑪刀市場

第16章：中國伽瑪刀市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Incorporated
  • Brainlab AG
  • Elekta AB（publ）
  • IBA Group SA
  • Mevion Medical Systems, Inc.
  • Nordion Inc.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • ViewRay, Inc.
Product Code: MRR-0D217D5AEF01

The Gamma Knife Market was valued at USD 401.05 million in 2025 and is projected to grow to USD 431.11 million in 2026, with a CAGR of 7.13%, reaching USD 649.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 401.05 million
Estimated Year [2026] USD 431.11 million
Forecast Year [2032] USD 649.68 million
CAGR (%) 7.13%

A concise foundational overview of Gamma Knife radiosurgery technology, clinical integration, and commercial dynamics shaping procurement and service models

Gamma Knife stereotactic radiosurgery remains a cornerstone technology in neurosurgical and radiosurgical treatment paradigms, combining sub-millimeter targeting precision with non-invasive delivery to treat complex intracranial pathologies. The device family encompasses legacy and modern platforms that vary by beam delivery architecture, workflow integration, and ancillary imaging and planning software. Clinical stakeholders continue to prioritize systems that minimize patient immobilization, optimize throughput, and integrate with multidisciplinary care pathways spanning neurosurgery, radiation oncology and neuro-oncology.

Commercially, the ecosystem around Gamma Knife systems includes direct OEM engagements, distributor relationships, and diverse end users ranging from tertiary hospitals to ambulatory surgical centers. Shifts in purchasing preferences and service contracting reflect a broader trend toward outcomes-driven procurement, where lifecycle service agreements, upgrade pathways and software-enabled value capture influence acquisition decisions. This introductory synthesis frames the subsequent analysis by linking clinical capability, channel dynamics and product evolution to the strategic considerations that matter to hospital executives, service line leaders and commercial teams.

How clinical advances, workflow efficiencies, and evolving procurement strategies are reshaping provider adoption and vendor competition in radiosurgical services

The Gamma Knife landscape is undergoing transformative shifts driven by technological innovation, evolving clinical pathways and changing commercial arrangements. Advances in stereotactic planning algorithms, integration with high-resolution MRI and the emergence of frameless workflows have broadened indications and improved patient experience, prompting more institutions to evaluate radiosurgery as a standard-of-care option for select brain lesions. These clinical advances have coincided with improvements in throughput and efficiency that influence where and how care is delivered, enabling adoption beyond traditional tertiary centers.

At the same time, competitive dynamics have matured. Competing radiation platforms and image-guided systems have intensified pressure on legacy product lines to demonstrate differentiated clinical outcomes and operational economics. Payment and reimbursement frameworks in several jurisdictions are becoming more procedure- and outcome-focused, compelling vendors and providers to document comparative effectiveness and resource utilization. Additionally, procurement strategies are shifting toward bundled service models and upgrade-first pathways, as hospitals seek to reduce large upfront capital expenditures and better predict total cost of ownership over multi-year horizons.

Assessing how cumulative tariff measures and import controls are influencing procurement timing, vendor pricing strategies, and supply chain resilience for radiosurgery systems

Recent tariff policy developments have introduced a new variable into capital equipment planning and supply chain resilience for Gamma Knife systems. Cumulative duties and associated import controls can affect the landed cost of complex medical devices, componentry and software-linked hardware upgrades, with ripple effects on vendor pricing strategies and institutional procurement timing. Procurement teams are increasingly incorporating tariff scenario planning into their capital approval processes to ensure contingency funding and avoid project delays tied to customs clearance or supplier repricing.

In response, original equipment manufacturers and distributors are adjusting their commercial approaches by localizing inventories, diversifying supplier bases for critical components and offering more flexible financing or upgrade-as-a-service arrangements. Transmission of tariff-related cost pressures to end users varies by contracting structure; long-term service agreements and locally stocked upgrade inventories can mitigate immediate price shocks, while institutions relying on ad-hoc purchasing may experience greater exposure. The combined effect is a re-emphasis on supply chain transparency, contractual clarity on price adjustments and enhanced collaboration between procurement, clinical engineering and vendor account teams to manage implementation timelines and budgetary impact.

Actionable insights from a granular segmentation framework showing how channels, end users, clinical applications, and product models determine adoption pathways and aftermarket demand

Deep segmentation analysis reveals differentiated adoption drivers and commercialization pathways across distribution channels, end users, applications and product types. Distribution channel dynamics include direct sales models, which encompass e-commerce initiatives and dedicated OEM sales teams, and distributor-led channels that operate through local and national distributor networks; each approach affects lead times, service responsiveness and opportunities for bundled offerings. End user segmentation captures a spectrum from ambulatory surgical centers, which include radiology and surgical centers focused on streamlined workflows, to hospitals that span community facilities and tertiary care centers with comprehensive multidisciplinary programs, and specialty clinics such as neurosurgery centers and oncology clinics that prioritize procedure-specific throughput and clinical outcomes.

Application-based segmentation shows distinct clinical and operational considerations for treating brain tumors-differentiating between primary and metastatic lesions-functional disorders such as movement disorders and trigeminal neuralgia, and vascular malformations including arteriovenous and cavernous variants; each indication drives unique planning protocols, imaging requirements and patient selection criteria. Product type segmentation reflects the installed base and upgrade pathways across legacy and modern platforms, with distinct purchase patterns for models including 4C, Icon, Model C and Perfexion, each offering new unit sales and upgrade packages; the interplay between available upgrades and end-user operational priorities significantly shapes replacement cycles and aftermarket service demand.

How regional regulatory frameworks, reimbursement dynamics, and provider infrastructure differences are shaping adoption patterns and commercial approaches across major global regions

Regional dynamics materially influence clinical adoption models, regulatory requirements and commercial execution for Gamma Knife systems. In the Americas, procurement decisions are shaped by a mix of large academic medical centers and community hospital systems, where reimbursement structures and network-level capital planning determine the cadence of upgrades and new installations. Transition to ambulatory settings is gaining traction where procedural reimbursement and patient throughput support decentralized radiosurgery delivery, while urban tertiary centers continue to invest in integrated multimodality programs.

In Europe, the Middle East and Africa, regulatory frameworks and national reimbursement policies create a heterogeneous operating environment that favors flexible commercial models and strong distributor partnerships to navigate local approvals and service expectations. Public healthcare procurement processes and centralized tendering in several countries necessitate compelling clinical and cost-effectiveness evidence. Asia-Pacific regions present a combination of rapid capacity expansion in major metropolitan centers and targeted investments in emerging markets; local manufacturing partnerships, training programs and scalable service models are proving effective to accelerate adoption while addressing workforce and infrastructure variability.

Why product differentiation, lifecycle service excellence, and channel partnerships determine competitive advantage and long-term vendor-provider alignment in radiosurgery

Competitive positioning within the Gamma Knife and broader stereotactic radiosurgery market depends on a combination of product differentiation, lifecycle service capabilities and channel execution. Leading vendors focus on demonstrating clinical precision, workflow integration and long-term serviceability, while adjacent competitors emphasize alternative beam delivery technologies and hybrid treatment offerings that appeal to centers seeking multifunctional platforms. Strategic partnerships between OEMs and hospital systems increasingly emphasize installed-base upgrades, training and software-enabled clinical decision support as levers to sustain long-term relationships.

Beyond headline manufacturers, a network of service providers, imaging partners and software developers plays a crucial role in enabling clinical value. Companies that invest in robust training ecosystems, remote monitoring capabilities and rapid parts distribution can extract additional value from installed systems and reduce downtime for providers. Additionally, OEMs and distributors that offer clear upgrade pathways for models like 4C, Icon, Model C and Perfexion can extend equipment lifecycles and offer more predictable total cost profiles, making their offerings more attractive to fiscally conservative procurement teams.

Practical strategic measures for vendors and providers to align product innovation, commercial flexibility, and service capability to accelerate adoption and mitigate policy risks

Industry leaders should adopt a multi-pronged strategy to navigate clinical, commercial and policy headwinds while capturing growth opportunities in radiosurgery. First, align product roadmaps with clinician needs by prioritizing frameless workflows, enhanced imaging integration and planning automation that reduce treatment times and expand eligible patient populations. Investing in continuous clinical evidence generation and peer-reviewed outcome data will strengthen procurement narratives and support inclusion in standardized care pathways.

Second, optimize commercial models by expanding flexible financing, upgrade-as-a-service offerings and localized inventory strategies to mitigate tariff-driven cost volatility and shorten implementation timelines. Strengthen channel partnerships by defining clear roles for direct sales teams versus local and national distributors, ensuring consistent service level agreements and knowledge transfer. Finally, invest in workforce enablement and digital service capabilities such as remote diagnostics and training platforms to improve uptime, support faster onboarding of new users and reinforce long-term customer relationships.

A transparent mixed-methods research approach combining stakeholder interviews and secondary evidence synthesis to validate clinical and commercial insights

This analysis synthesizes insights derived from a mixed-methods research approach that blends primary stakeholder engagement with rigorous secondary evidence synthesis. Primary engagement included structured interviews and discussions with clinical leaders, procurement specialists, clinical engineers and vendor account executives to capture frontline perspectives on device selection criteria, workflow priorities and contractual preferences. These conversations informed qualitative understanding of adoption barriers, service expectations and upgrade rationales across different facility types.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, policy announcements and publicly available product documentation to validate clinical performance claims and situate technology evolution within regulatory contexts. The methodology incorporated cross-validation between primary insights and secondary sources to identify convergent themes and to flag areas requiring closer monitoring. Analytical rigor was maintained through iterative triangulation, ensuring that conclusions reflect consistent patterns observed across multiple information streams and stakeholder groups.

A consolidated closing synthesis highlighting strategic priorities, supply chain resilience, and evidence alignment to support sustainable radiosurgery adoption

In closing, the Gamma Knife domain is at an inflection point where clinical innovation, supply chain dynamics and evolving procurement models intersect. Providers and vendors that proactively adapt to frameless workflows, invest in interoperable planning and imaging solutions, and deploy flexible commercial models will be better positioned to capture emerging demand and strengthen long-term partnerships. Tariff-induced cost pressures underscore the importance of supply chain diversification and local service capabilities to preserve implementation timelines and predictability of total lifecycle costs.

Looking ahead, success will hinge on aligning clinical evidence generation with procurement narratives, leveraging segmentation insights to tailor channel and product strategies, and building resilient service infrastructures that keep systems operational and clinicians confident. Institutions that integrate these considerations into capital planning and clinical strategy will be well-equipped to expand access to precision radiosurgery while maintaining fiscal discipline and operational excellence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gamma Knife Market, by Product Type

  • 8.1. 4C
    • 8.1.1. New Units
    • 8.1.2. Upgrades
  • 8.2. Icon
    • 8.2.1. New Units
    • 8.2.2. Upgrades
  • 8.3. Model C
    • 8.3.1. New Units
    • 8.3.2. Upgrades
  • 8.4. Perfexion
    • 8.4.1. New Units
    • 8.4.2. Upgrades

9. Gamma Knife Market, by Application

  • 9.1. Brain Tumors
    • 9.1.1. Metastatic Brain Tumors
    • 9.1.2. Primary Brain Tumors
  • 9.2. Functional Disorders
    • 9.2.1. Movement Disorders
    • 9.2.2. Trigeminal Neuralgia
  • 9.3. Vascular Malformations
    • 9.3.1. Arteriovenous Malformations
    • 9.3.2. Cavernous Malformations

10. Gamma Knife Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Radiology Centers
    • 10.1.2. Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Community Hospitals
    • 10.2.2. Tertiary Care Hospitals
  • 10.3. Specialty Clinics
    • 10.3.1. Neurosurgery Centers
    • 10.3.2. Oncology Clinics

11. Gamma Knife Market, by Distribution Channel

  • 11.1. Direct Sales
    • 11.1.1. E Commerce
    • 11.1.2. Oem Sales Team
  • 11.2. Distributor
    • 11.2.1. Local Distributors
    • 11.2.2. National Distributors

12. Gamma Knife Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gamma Knife Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gamma Knife Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gamma Knife Market

16. China Gamma Knife Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accuray Incorporated
  • 17.6. Brainlab AG
  • 17.7. Elekta AB (publ)
  • 17.8. IBA Group S.A.
  • 17.9. Mevion Medical Systems, Inc.
  • 17.10. Nordion Inc.
  • 17.11. Shinva Medical Instrument Co., Ltd.
  • 17.12. Siemens Healthineers AG
  • 17.13. Varian Medical Systems, Inc.
  • 17.14. ViewRay, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GAMMA KNIFE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GAMMA KNIFE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL GAMMA KNIFE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 281. GCC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. GCC GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. GCC GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 284. GCC GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 285. GCC GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 286. GCC GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 287. GCC GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. GCC GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 289. GCC GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 290. GCC GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 291. GCC GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. GCC GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 293. GCC GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 294. GCC GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 295. GCC GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. GCC GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 297. GCC GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 332. G7 GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 333. G7 GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. G7 GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 335. G7 GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 336. G7 GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 337. G7 GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 338. G7 GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. G7 GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 340. G7 GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 341. G7 GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 342. G7 GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. G7 GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 344. G7 GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 345. G7 GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 346. G7 GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 347. G7 GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 348. G7 GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 349. NATO GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 350. NATO GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. NATO GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2032 (USD MILLION)
  • TABLE 352. NATO GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2032 (USD MILLION)
  • TABLE 353. NATO GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2032 (USD MILLION)
  • TABLE 354. NATO GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2032 (USD MILLION)
  • TABLE 355. NATO GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 356. NATO GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
  • TABLE 357. NATO GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 358. NATO GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2032 (USD MILLION)
  • TABLE 359. NATO GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. NATO GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 361. NATO GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 362. NATO GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 363. NATO GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 364. NATO GAMMA KNIFE MARKET SIZE, BY DIRECT SALES,